Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • EpiPen

    - PMLiVE

    Novo Nordisk agrees to lower certain drug prices in the US

    The company's semaglutide-based weight-loss drugs will be made available in the US through Medicare and Medicaid

    - PMLiVE

    Lilly announces agreement with US government to lower patient costs

    The agreement will make insulin and obesity treatments more affordable through federal programmes and direct-to-patient channels

    Genesis Research Group A&P image

    Strategy. Insights. Access. Genesis Research Group outlines its integrated, data-driven solutions for US and global access and pricing.

    In today’s rapidly evolving environment, US and global access and pricing decisions demand robust evidence, rigorous analysis, and strategic precision. Following Genesis Research Group's recent expansion of its real-world data...

    Genesis Research Group

    - PMLiVE

    Communicating value to US Payers: Insights for Pharma and Medtech

    What do global market access teams need to know about the US market? What do US payers expect to hear from Pharma and Medtech companies? What kind of value messaging...

    Petauri Evidence

    - PMLiVE

    What is willingness to pay? – Comparing price testing methodologies

    Heather Wellam (Senior Consultant – Market Access, Mtech Access) explores the concept of willingness to pay (WTP) and what it means for pharmaceutical and medtech pricing strategy. Read on to...

    Petauri Evidence

    - PMLiVE

    Kathy O’Connell joins Research Partnership as Senior Vice President, Business Development

    Kathy has been working in the pharmaceutical market research industry for over 25 years. She has a diverse business background, with in-depth experience in progressively responsible sales, business development and...

    Inizio

    - PMLiVE

    Ten participating drugmakers invited for further US Medicare drug price negotiations

    ASPE revealed that the IRA is expected to save around 857,000 US women $1,000 or more in 2025

    - PMLiVE

    Drugmakers submit counteroffers to US Medicare pricing negotiations

    New negotiated prices are set to be announced by 1 September 2024 and implemented in 2026

    Top 10 HEOR trends – A detailed look at ISPOR’s 2024–2025 topics

    Top 10 HEOR trends – A detailed look at ISPOR’s 2024–2025 topics

    Specialists from across Mtech Access to look at each of ISPOR’s top 10 HEOR trends for 2024–2025. Jump in as the Mtech Access experts give their hot take on each...

    Petauri Evidence

    - PMLiVE

    US backs proposal to waive IP protection for COVID-19 vaccines

    "Monumental decision" could see IP protections for COVID-19 vaccines temporarily removed

    - PMLiVE

    Pfizer, Sanofi and others set to increase US drug prices in 2021

    Pressure from COVID-19 restrictions leads to drug price increases

    - PMLiVE

    Pfizer, Mylan move ahead with generics merger and spin-out

    The merger had faced a set-back as a result of COVID-19 disruption

    Subscribe to our email news alerts

    Latest content

    Latest intelligence

    Quick links